Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Aspartate - Glutamate
Active Ingredients: Monosodium glutamate 228mmol/L
Sodium aspartate 228mmol/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Biomed Limited
Manufacturer: Biomed Limited, Pt Chevalier, Auckland
Note: This consent is valid for two years from the 26 April 2007.
Product: Rescriptor
Active Ingredient: Delavirdine mesilate 100mg equivalent to 82.6mg delavirdine base
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer Pharmaceuticals LLC, Arecibo, Puerto Rico
Note: This consent is valid for two years from 1 March 2007.
Dated this 22nd day of February 2007
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).